Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis
Viruses · 2025
DOI: 10.3390/v17070906 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Viruses, 2025. Verfasst von Alessia Siribelli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Vita-Salute San Raffaele University, 20132 Milan, Italy. Hauptthemen laut MEDLINE: HIV Infections, Metabolome, Fatty Liver, Hepatitis C, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In HCV-coinfected people with HIV (PWH), there are still conflicting data regarding the long-term metabolic impact of HCV eradication. The aim of the study is to investigate long-term changes in controlled attenuation parameter (CAP) and metabolic profile after sustained virological response (SVR) post-direct acting antivirals (DAAs) in PWH. This is a retrospective observational study including individuals with HIV/HCV coinfection, followed as outpatients at San Raffaele Hospital, who achieved SVR post-DAAs. Individuals were assessed for metabolic parameters before and after the start of DAAs. Univariate and multivariate mixed linear models were calculated to estimate crude mean changes in CAP, metabolic parameters, and weight; slopes were reported with the corresponding 95% confidence intervals (95% CI). Overall, during a median follow-up of 4.02 years (interquartile range, IQR 3.04–4.80), the mean percent increase in CAP was 2.86/year (p < 0. 0001), and the mean decrease in stiffness was –4.28 (p = 0.003). Additionally, total cholesterol (p < 0.0001), high-density lipoprotein (HDL) cholesterol (p = 0.001), triglycerides (p < 0.0001), glucose (p < 0.0001), and Body Mass Index (BMI) (p < 0.0001) increased over time. A long-term follow-up in PWH with SVR post-DAAs showed an overall significant increase in CAP and worsening of the metabolic profile, suggesting a higher risk of developing liver steatosis and metabolic alterations over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Vita-Salute San Raffaele University, 20132 Milan, Italy.
- Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy.
ORCID-Profile: Alessia Siribelli, Camilla Muccini, Giulia Morsica, Riccardo Lolatto, Tommaso Clemente, Costanza Bertoni
Zitieren
APA
Siribelli, A., Diotallevi, S., Galli, L., Muccini, C., Morsica, G., Lolatto, R., Clemente, T., Messina, E., Bertoni, C., Uberti-Foppa, C., Castagna, A., & Hasson, H. (2025). Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis. Viruses. https://doi.org/10.3390/v17070906
Vancouver
Siribelli A, Diotallevi S, Galli L, Muccini C, Morsica G, Lolatto R, et al. Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis. Viruses. 2025. doi:10.3390/v17070906
BibTeX
@article{Siribelli2025,
author = {Siribelli, Alessia and Diotallevi, Sara and Galli, Laura and Muccini, Camilla and Morsica, Giulia and Lolatto, Riccardo and Clemente, Tommaso and Messina, Emanuela and Bertoni, Costanza and Uberti-Foppa, Caterina and Castagna, Antonella and Hasson, Hamid},
title = {Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17070906}
}
EUVIMED